CreatorsPublishersAdvertisers
View more in
Cancer

MRD Has Potential to Predict Outcomes for Patients With Myeloma Post-Stem Cell Transplantation

cancernetwork.com
 2021-09-10

Cover picture for the articleMinimal residual disease negativity may predict outcomes for patients with multiple myeloma on maintenance therapy with lenalidomide who previously underwent autologous stem cell transplantation. Minimal residual disease (MRD) negativity may predict outcomes for patients with multiple myeloma on maintenance therapy with lenalidomide (Revlimid) who previously underwent autologous stem cell...

www.cancernetwork.com

Comments / 0

Comments / 0